Publications by authors named "Francesca Negri"

Claim this Profile
E
Editorial: Advances in molecular biology knowledge of rectal cancer and forthcoming role of liquid biopsy.
Francesca Negri, Letizia Gnetti, Carlo Aschele

Front Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatocellular carcinoma, vascular endothelial growth factor receptors-targeting agents, and hypertension: A much more complicated relationship than expected.
Camillo Porta, Francesca Negri, Laura Cosmai

Cancer· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New Tricholomalides D-G from the Mushroom Grown in an Italian Beech Wood.
Gianluca Gilardoni, Francesca Negri, Paola Vita Finzi, Faiq H S Hussain, Giovanni Vidari

Molecules· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New Tricholidic Acid Triterpenoids from the Mushroom Collected in an Italian Beech Wood.
Gianluca Gilardoni, Francesca Negri, Paola Vita Finzi, Faiq H S Hussain, Giovanni Vidari

Molecules· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Notch-Jagged1 signaling and response to bevacizumab therapy in advanced colorectal cancer: A glance to radiomics or back to physiopathology?
Francesca Negri, Lorena Bottarelli, Giuseppe Pedrazzi, Michele Maddalo, Ludovica Leo

Front Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unconsolidated Results of Consolidation Chemotherapy Following Short-Course Radiotherapy in Locally Advanced Rectal Cancer.
Francesca Negri, Carlo Aschele

J Clin Oncol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting development of distant metastases and long-term outcome of locally advanced rectal cancer treated with neoadjuvant chemotherapy and radiation.
Carlo Aschele, Francesca Negri

Ann Transl Med· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of the lockdown period on the mental health of elite athletes during the COVID-19 pandemic: a narrative review.
Vittoria Carnevale Pellino, Nicola Lovecchio, Mariangela V Puci, Luca Marin, Alessandro Gatti, Francesca Negri

Sport Sci Health· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KRAS: A Druggable Target in Colon Cancer Patients.
Francesca Negri, Lorena Bottarelli, Gian Luigi de'Angelis, Letizia Gnetti

Int J Mol Sci· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatocellular cancer therapy in patients with HIV infection: Disparities in cancer care, trials enrolment, and cancer-related research.
Francesca Negri, Gabriele Missale, Anna Degli Antoni, Camillo Porta

Transl Oncol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sorafenib and hepatocellular carcinoma: is alpha-fetoprotein a biomarker predictive of tumor biology and primary resistance?
Francesca Negri, Letizia Gnetti, Giuseppe Pedrazzi, Enrico Maria Silini, Camillo Porta

Future Oncol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Donafenib in Chinese patients with advanced hepatocellular carcinoma (HCC): Really a new standard of care, or should we change paradigm for drug development in HCC?
Francesca Negri, Camillo Porta

Oncol Rev· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nab-paclitaxel/gemcitabine combination is more effective than gemcitabine alone in locally advanced, unresectable pancreatic cancer - A GISCAD phase II randomized trial.
Stefano Cascinu, Rossana Berardi, Roberto Bianco, Domenico Bilancia, Alberto Zaniboni, Francesca Negri

Eur J Cancer· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterogeneity of Colorectal Cancer Progression: Molecular Gas and Brakes.
Federica Gaiani, Federica Marchesi, Francesca Negri, Luana Greco, Alberto Malesci

Int J Mol Sci· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
rearrangements are uncommon in biliary tract cancers.
Francesca Mazzoni, Paolo Petreni, Enrico Vasile, Michele Panebianco, Andrea Casadei-Gardini, Francesca Negri

Oncol Lett· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic and Predictive Cross-Roads of Microsatellite Instability and Immune Response to Colon Cancer.
Luigi Laghi, Francesca Negri, Federica Gaiani, Tommaso Cavalleri, Fabio Grizzi

Int J Mol Sci· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical impact of first-line bevacizumab plus chemotherapy in metastatic colorectal cancer of mucinous histology: a multicenter, retrospective analysis on 685 patients.
Vincenzo Catalano, Francesca Bergamo, Chiara Cremolini, Bruno Vincenzi, Francesca Negri

J Cancer Res Clin Oncol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High levels of Notch intracellular cleaved domain are associated with stemness and reduced bevacizumab efficacy in patients with advanced colon cancer.
Francesca Negri, Cecilia Bozzetti, Giuseppe Pedrazzi, Cinzia Azzoni, Lorena Bottarelli

Oncol Rep· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A validated prognostic classifier for BRAF-mutated metastatic colorectal cancer: the 'BRAF BeCool' study.
Fotios Loupakis, Rossana Intini, Chiara Cremolini, Armando Orlandi, Andrea Sartore-Bianchi, Francesca Negri

Eur J Cancer· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medical Treatment of Advanced Hepatocellular Carcinoma Patients: The Issue Is Not the Right Drug, but the Right Patient.
Camillo Porta, Chiara Broglia, Francesca Negri

Hepatology· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of laterality and mucinous histology on relapse-free and overall survival in a registry-based colon cancer series.
Francesca Negri, Annamaria De Giorgi, Annalisa Gilli, Cinzia Azzoni, Lorena Bottarelli

Sci Rep· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter prospective study of angiogenesis polymorphism validation in HCC patients treated with sorafenib. An INNOVATE study protocol.
Andrea Casadei Gardini, Luca Faloppi, Giuseppe Aprile, Oronzo Brunetti, Chiara Caparello, Francesca V Negri

Tumori· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microsatellite instability in colorectal cancer.
Gian Luigi De' Angelis, Lorena Bottarelli, Cinzia Azzoni, Nicola De' Angelis, Gioacchino Leandro, Francesca Negri

Acta Biomed· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential predictive biomarkers in locally advanced rectal cancer treated with preoperative chemo-radiotherapy.
Lorena Bottarelli, Gian Luigi De' Angelis, Cinzia Azzoni, Francesco Di Mario, Nicola De' Angelis, Francesca Negri

Acta Biomed· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tivantinib for second-line treatment of MET-high, advanced hepatocellular carcinoma (METIV-HCC): a final analysis of a phase 3, randomised, placebo-controlled study.
Lorenza Rimassa, Eric Assenat, Markus Peck-Radosavljevic, Marc Pracht, Vittorina Zagonel, Francesca Negri

Lancet Oncol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis